MedTrace Logo

Study of Pain Control in Hemorrhoidectomy

NCT00890721 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2013-08-06

Study results available
· View outcomes & findings →

Summary

Patients will get an injection of either SKY0402 or placebo during hemorrhoid surgery, and their pain and pain medicine use will be monitored.

Conditions

  • Hemorrhoid

Interventions

DRUG

SKY0402

During the operation, 30cc of SKY0402 are injected into the wound.

DRUG

Placebo

During the hemorrhoidectomy, 30cc Placebo injected into the wound.

Sponsors & Collaborators

  • Pacira Pharmaceuticals, Inc

    lead INDUSTRY

Principal Investigators

  • Zbigniew Śledziński, MD · General Surgery, Transplantology and Endocrinology Department, Gdansk

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00890721 on ClinicalTrials.gov